---
title: Publications
permalink: /publications/
header:
  image: /assets/images/moro-crop2.jpg
---

## Books
- **Case Studies in Bayesian Methods for CMC Applications** P. Faya and T. Pourmohamad. To appear in CRC Press.
- **Bayesian Optimization with Application to Computer Experiments** (2021). T. Pourmohamad and H.K.H Lee. Springer Cham. [[link]([http://clincancerres.aacrjournals.org/content/early/2019/02/15/1078-0432.CCR-18-2740.abstract?casa_token=LiE4CMwwEMgAAAAA:9klg5HYecBTePpF8btXVJyJjbdTcHV8aNahPBx_muABv9C9mBJETT6Zm7AFeZ2LdQGg3px39GhxJXLhN0A](https://link.springer.com/book/10.1007/978-3-030-82458-7))]

## Journal Articles

- **The Utility of Novel Biomarkers in Mice for Drug Development Studies**. A.O. Adedeji, T. Pourmohamad, Y.-Z. Gu, J. Kanerva, Y. Chen, E. Atabakhsh, M. Tackett, F. Chen, B. Bhatt, T. Gury, O. Dorchies, M. Sonee, M. Morgan, J. Burkey, J.-C. Gautier, J. McDuffie. International Journal of Toxicology. 40(1):15-25.[[link](https://journals.sagepub.com/doi/10.1177/1091581820970498)]
- **The Statistical Filter Approach to Constrained Optimization** (2020). T. Pourmohamad and H.K.H. Lee. Technometrics. 62(3):303-312 [[link](https://doi.org/10.1080/00401706.2019.1638304)]
- **Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GCD-0919) Administered with PD-l1 Inhibitor (Atezolizumab) in Adavnced Solid Tumors** (2019).
K.H. Jung, P.M. LoRusso, H.A. Burris, M.S. Gordon, Y. Bang, M.D. Hellman, A. Cervantes, M. Ochoa de Olza, A. Marabelle, F.S. Hodi, M. Ahn, L.A. Emens, F. Barlesi, O. Hamid, E. Calvo, D.F. McDermott, H. Soliman, I. Rhee, R. Lin, T. Pourmohamad, J. Suchomel, A. Tsuhako, K.M. Morrissey, S. Mahrus, R. Morley, A. Pirzkall, S.L. Davis. Clinical Cancer Research. [[link](http://clincancerres.aacrjournals.org/content/early/2019/02/15/1078-0432.CCR-18-2740.abstract?casa_token=LiE4CMwwEMgAAAAA:9klg5HYecBTePpF8btXVJyJjbdTcHV8aNahPBx_muABv9C9mBJETT6Zm7AFeZ2LdQGg3px39GhxJXLhN0A)]
- **Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization
for Drug Development Studies** (2019).
A.O. Adedeji, T. Pourmohamad, Y. Chen, J. Burkey, C.J. Bettes, S.J. Bickerton, M. Sonee, J.E. McDuffie. International Journal of Toxicology. 38(1):12-22 [[link](https://journals.sagepub.com/doi/abs/10.1177/1091581818819791?casa_token=zWCDgta3dP4AAAAA:Hpp7e-GXLGP1-tYeZ1sey8BXkZfGABn14SZAi9raoT9lIHMuG43ishE7bYgB8oATrz12EcrkWUAmwA)]
- **Phase I Study of the Anti-beta5-alpha1 Monoclonal Antibody MINT1526A With or Without Bevacizumab in Patients with Advanced Solid Tumors** (2018).
C.D. Weekes, L.S. Rosen, A. Capasso, K.M. Wong, W. Ye, M. Anderson, B. McCall, J. Fredrickson, E.
Wakshull, S. Eppler, Q. Shon-Nguyen, R. Desai, M. Huseni, P.S. Hedge, T. Pourmohamad, I. Rhee, A.
Bessudo. Cancer Chemotherapy and Pharmacology. 82(2):339-351 [[link](https://rd.springer.com/article/10.1007/s00280-018-3622-8)]
- **Multivariate Stochastic Process Models for Correlated Responses of Mixed Type** (2016).
T. Pourmohamad and H.K.H. Lee. Bayesian Analysis. 11 (3):797-820 [[link](https://projecteuclid.org/euclid.ba/1444308210)]
- **Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment** (2012).
A. Bharatha, M.E. Faughnan, H. Kim, T. Pourmohamad, C.E. McCulloch, M.T. Lawton, C. Dowd, T.
Krings, W.L. Young, and K.G. Terbrugge. Stroke. 43:72-78 [[link](https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.111.629865)]
- **Silent Intralesional Microhemorrhage as a Risk Factor for Brain Arteriovenous Malformation Rupture** (2012).
Y. Guo, T. Saunders, H. Su, H. Kim, D. Akkoc, D.A. Saloner, S. Hetts, C. Hess, M.T. Lawton, A.W.
Bollen, T. Pourmohamad, C.E. McCulloch, T. Tihan, W.L. Young. Stroke. 43:1240-1246 [[link](https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.111.647263)]
- **An Admission Bioclinical Score to Predict 1-Year Outcomes in Patients Undergoing Aneurysm Coiling** (2012).
V. Degos, C.C. Apfel, P. Sanchez, C. Colonne, I. Renuit, F. Claran√ßon, A. Nouet, A.L. Boch, T. Pourmohamad,
H. Kim, P.A. Gourraud, W.L. Young, L. Puybasset. Stroke. 43:1253-1259 [[link](https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.111.638197)]
- **Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue** (2012). 
M.P. Kahle, B. Lee, T. Pourmohamad, A. Cunningham, H. Su, H. Kim, Y. Chen, C.E. McCulloch,
N.M. Barbaro, M.T. Lawton, W.L. Young, G.J. Bix. Neuroreport. 23(10):627-30 [[link](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535489/)]
- **Evaluating Performance of a New Combined Grading Scale for Selecting Patients with Brain Arteriovenous Malformations for Surgery** (2012).
H. Kim, T. Pourmohamad, C.E. McCulloch, M.T. Lawton, and W.L. Young. Stroke. 43(9):2497-9 [[link](https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.112.661942)]
- **Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: Gene-phenotype
correlations** (2012).
T. Nishida, M.E. Faughnan, T. Krings, M. Chakinala, J.R. Gossage, W.L. Young, H. Kim, T. Pourmohamad,
K.J. Henderson, S.D. Schrum, M. James, N. Quinnine, A. Bharatha, K.G. Terbrugge, R.I. White Jr. American Journal of Medical Genetics. 158A(11):2829-34 [[link](https://www.ncbi.nlm.nih.gov/pubmed/22991266)]
- **Cerebellar Arteriovenous Malformations: Anatomical Subtypes, Surgical Results, and Increased Predictive Accuracy of the
Supplementary Grading System** (2012).
A. Rodriguez-Hernandez, H. Kim, T. Pourmohamad, W.L. Young, and M.T. Lawton. Neurosurgery. 71(6):1111-24 [[link](https://www.ncbi.nlm.nih.gov/pubmed/22986595)]
